Proteomics

Dataset Information

0

THRONCAT: Efficient metabolic labelling of newly synthesized proteins using a bioorthogonal threonine analogue


ABSTRACT: Profiling the nascent cellular proteome and capturing early proteomic changes in response to external stimuli provides valuable insight into cellular physiology. Existing metabolic protein labelling approaches based on bioorthogonal methionine- or puromycin analogueues allow for the selective visualization and enrichment of the newly synthesized proteins, however, their applications are limited as they require methionine-free conditions or are toxic to cells. Here, we introduce a novel threonine-derived non-canonical amino acid tagging method, THRONCAT, based on bioorthogonal threonine analogueue β-ethynyl serine (βES) that enables efficient and non-toxic labelling of the nascent proteome in complete growth media within minutes. We used THRONCAT for the visualization and enrichment of nascent proteins in bacteria, mammalian cells, and drosophila melanogaster and rapidly profiled proteomic changes of Ramos B-cells in response to receptor activation in a time-stamp approach, demonstrating the potential and ease-of-use of the method.

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, Cell Suspension Culture, Hela Cell

SUBMITTER: Jelmer Dijkstra  

LAB HEAD: Michiel Vermeulen

PROVIDER: PXD032368 | Pride | 2023-07-20

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

THRONCAT: metabolic labeling of newly synthesized proteins using a bioorthogonal threonine analog.

Ignacio Bob J BJ   Dijkstra Jelmer J   Mora Natalia N   Slot Erik F J EFJ   van Weijsten Margot J MJ   Storkebaum Erik E   Vermeulen Michiel M   Bonger Kimberly M KM  

Nature communications 20230608 1


Profiling the nascent cellular proteome and capturing early proteomic changes in response to external stimuli provides valuable insights into cellular physiology. Existing metabolic protein labeling approaches based on bioorthogonal methionine- or puromycin analogs allow for the selective visualization and enrichment of newly synthesized proteins. However, their applications are limited as they often require methionine-free conditions, auxotrophic cells and/or are toxic to cells. Here, we introd  ...[more]

Similar Datasets

2023-08-30 | PXD038632 | Pride
2024-10-02 | PXD043942 | Pride
2023-10-26 | PXD032046 | Pride
2023-04-28 | PXD033831 | Pride
2010-07-01 | E-GEOD-4306 | biostudies-arrayexpress
2023-05-10 | PXD022806 | Pride
2021-09-09 | PXD022794 | Pride
2011-12-09 | E-GEOD-33671 | biostudies-arrayexpress
2013-02-28 | E-GEOD-38964 | biostudies-arrayexpress
2010-12-03 | E-MEXP-2680 | biostudies-arrayexpress